Compare ORCL & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ORCL | TMO |
|---|---|---|
| Founded | 1977 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Machinery/Components |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 865.6B | 216.4B |
| IPO Year | 1986 | N/A |
| Metric | ORCL | TMO |
|---|---|---|
| Price | $202.01 | $605.23 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 32 | 19 |
| Target Price | $309.75 | ★ $637.78 |
| AVG Volume (30 Days) | ★ 26.8M | 1.8M |
| Earning Date | 12-10-2025 | 01-29-2026 |
| Dividend Yield | ★ 0.98% | 0.28% |
| EPS Growth | ★ 30.21 | 8.54 |
| EPS | 5.33 | ★ 17.32 |
| Revenue | ★ $61,016,000,000.00 | $43,736,000,000.00 |
| Revenue This Year | $19.03 | $4.33 |
| Revenue Next Year | $29.60 | $4.98 |
| P/E Ratio | $38.43 | ★ $35.54 |
| Revenue Growth | ★ 11.07 | 3.22 |
| 52 Week Low | $118.86 | $385.46 |
| 52 Week High | $345.72 | $628.08 |
| Indicator | ORCL | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 50.85 | 57.73 |
| Support Level | $186.15 | $603.99 |
| Resistance Level | $195.67 | $624.79 |
| Average True Range (ATR) | 5.61 | 13.06 |
| MACD | 2.45 | 2.36 |
| Stochastic Oscillator | 73.26 | 57.98 |
Oracle provides enterprise applications and infrastructure offerings around the world through a variety of flexible IT deployment models, including on-premises, cloud-based, and hybrid. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system, which is commonly used for running online transaction processing and data warehousing workloads. Besides database systems, Oracle also sells enterprise resource planning, or ERP, customer relationship management, or CRM, and human capital management, or HCM, applications. Today, Oracle has more than 159,000 full-time employees in over 170 countries.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).